Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses-Reference-Cited by-同舟云学术

Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses

Published:2020-06 Issue:11 Volume:31 Page:107762
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

de Witte Chris Jenske,Espejo Valle-Inclan Jose,Hami Nizar,Lõhmussaar Kadi,Kopper Oded,Vreuls Celien Philomena Henrieke,Jonges Geertruida Nellie,van Diest Paul,Nguyen Luan,Clevers Hans,Kloosterman Wigard Pieter,Cuppen Edwin,Snippert Hugo Johannes Gerhardus,Zweemer Ronald Peter,Witteveen Petronella Oda,Stelloo Ellen

Funder

Gieskes Strijbis Foundation

Dutch Cancer Society

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference51 articles.

1. Targeted deletion of Wwox reveals a tumor suppressor function;Aqeilan;Proc. Natl. Acad. Sci. USA,2007

2. Xenograft and organoid model systems in cancer research;Bleijs;EMBO J.,2019

3. Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data;Boeva;Bioinformatics,2012

4. Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma;Böhm;J. Clin. Oncol.,2015

5. Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents;Bunn;Clin. Cancer Res.,2001

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered nano-aluminum adjuvant for cancer immunotherapy: Progress, challenges and opportunities towards preclinical/clinical application;Coordination Chemistry Reviews;2024-11

2. Advances and challenges in the origin and evolution of ovarian cancer organoids;Frontiers in Oncology;2024-08-16

3. Phenotyping Tumor Heterogeneity through Proteogenomics: Study Models and Challenges;International Journal of Molecular Sciences;2024-08-14

4. Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism;OncoImmunology;2024-07-09

5. Organoid Models Derived from Primary Tumors and Patient-Derive Xenograft Tumors Reflect Platinum Sensitivity of Ovarian Cancer Patients;2024-07-02